This wiki has undergone a migration to Confluence found Here
<meta name="googlebot" content="noindex">

Difference between revisions of "CG WG Call Notes leading to 2012 May WGM"

From HL7Wiki
Jump to navigation Jump to search
Line 54: Line 54:
  
 
==Attendees==
 
==Attendees==
* Amnon Shabo
+
* Amnon Shabo. IBM
 
* Mollie Ullman-Cullere
 
* Mollie Ullman-Cullere
* Daryl Thomas
+
* Daryl Thomas. Life Technologies
 
* Dipesh Risal. Illumnina
 
* Dipesh Risal. Illumnina
 
* Steve Burgett. Illumina Dir SW Dev
 
* Steve Burgett. Illumina Dir SW Dev
Line 64: Line 64:
 
* Costa Makrodimitris. ONC/S&I
 
* Costa Makrodimitris. ONC/S&I
 
* Scott Bolte.  GE Healthcare
 
* Scott Bolte.  GE Healthcare
 +
* Joyce Hernandez. Merck
  
 
==Draft Minutes==
 
==Draft Minutes==
*
+
* Approved Pedigree R1 Reaffirmation PSS (Risal and Burgett abstained; all others approved). Thomas to submit to DESD for approval.
 +
* Amended and approved Gene Expression PSS (Burgett and Makodimitris had left; Babb and Risal abstained; all others approved). Hernandez to submit to DESD for approval.
 +
* CDA Implementation Guide for Genetic Testing Reports PSS to be amended by Amnon and circulated for review and approval by email.  Voted to extend DMP to allow email voting for this specific PSS.
 +
* Amnon will amend DMP to include email approval process and will circulate to the group for review at the next call.
 +
* Postponed approval of the 2012 WGM draft minutes to next call.
 +
* initiated clinical sequencing focus group to meet on Thursday mornings at 8 AM PST.  First meeting January 26.  Contact daryl.thomas@lifetech.com for details now (will be documented later).  Initial group is Thomas, Ullman-Cullere, Shabo, Hernandez, Babb, Risal, Wood, and Bolte.
 +
* postponed other items to next call

Revision as of 17:21, 24 January 2012

Back to Agendas and Minutes.

January 31, 2012

Agenda

  • Ballot Reconciliation
    • Cytogenetics
    • Genetic Variation
    • GTR
      • CAP and ACMG harmonization
  • Group Health
    • DMP - Amnon to edit and circulate for review
  • Product guide
  • 2012 Jan WGM minutes review/approval

Attendees

Draft Minutes

January 24, 2012

Agenda

  • Introduction of Illumina stakeholders
  • Approval of 2012 January WGM minutes
  • Group Health Issues (Status and Descriptions)
    • Mission and Charter
    • Decision Making Practices
    • 3 year plan
    • Post WGM Survey
    • SD participation at WGM -- Mollie to correct September 2011 bookkeeping
    • SD participation on weekly calls -- plan for co-chair involvement
    • Project review (Project Insight)
      • 844 Family Health History and Pedigree standard, Release 2; On Track; SD Approval 12/16/2012
      • 841 Clinical Sequencing; On Track; SD Approval 12/16/2012
      • 752 Publish CDA IGs from Tooling; Sponsored by Structured Documents Work Group; past deadline: 2011 May WGM
      • 729 Canonical Pedigree (Family History) Interoperability Implementation Guide; On Hold
      • 705 HL7 CG- omics Domain Analysis Model; past deadline - 2011 September WGM
      • 693 Clinical Genomics - Genetic Variation (CMET); past deadline - 2011 September WGM
      • 692 Clinical Genomics - Genetic Variation (Fully LOINC- Qualified Genetic Variation Model); On Track
      • 663 Cytogenetic Lab Results; On Track? Adjust project end date
      • 565 Specimen Handling CMET; Move to O&O
      • 564 Connection with Decision Support; Place on hold
      • 479 Health Informatics: Clinical Genomics Pedigree Topic (ISO Ballot Project); past deadline - 2011 September WGM; Approved 3/30/2009 - Place on hold
      • 460 CDA Implementation Guide for Genetic Testing Reports; Approved 2/24/2009 - re-submit PSS
      • 333 Gene Expression; past deadline - 2011 September WGM; Approved 1/27/2009 - re-submit PSS
  • Approval of updated Project Scope Statements (These need to be approved and submitted by January 29, which is before our next call.)
    • 460 CDA Implementation Guide for Genetic Testing Reports; Approved 2/24/2009
    • 333 Gene Expression; past deadline - 2011 September WGM; Approved 1/27/2009
  • Planning Clinical Sequencing work for May 2012 Informative ballot (Due February 26)
    • Use Cases
    • Class Models
    • Activity Diagrams
  • Vancouver WGM agenda / joint sessions / room reservations
  • Other new business

Attendees

  • Amnon Shabo. IBM
  • Mollie Ullman-Cullere
  • Daryl Thomas. Life Technologies
  • Dipesh Risal. Illumnina
  • Steve Burgett. Illumina Dir SW Dev
  • Mukesh Sharma. WUSTL
  • Larry Babb. Parnters. SW Developer
  • Grant Wood. Intermountain
  • Costa Makrodimitris. ONC/S&I
  • Scott Bolte. GE Healthcare
  • Joyce Hernandez. Merck

Draft Minutes

  • Approved Pedigree R1 Reaffirmation PSS (Risal and Burgett abstained; all others approved). Thomas to submit to DESD for approval.
  • Amended and approved Gene Expression PSS (Burgett and Makodimitris had left; Babb and Risal abstained; all others approved). Hernandez to submit to DESD for approval.
  • CDA Implementation Guide for Genetic Testing Reports PSS to be amended by Amnon and circulated for review and approval by email. Voted to extend DMP to allow email voting for this specific PSS.
  • Amnon will amend DMP to include email approval process and will circulate to the group for review at the next call.
  • Postponed approval of the 2012 WGM draft minutes to next call.
  • initiated clinical sequencing focus group to meet on Thursday mornings at 8 AM PST. First meeting January 26. Contact daryl.thomas@lifetech.com for details now (will be documented later). Initial group is Thomas, Ullman-Cullere, Shabo, Hernandez, Babb, Risal, Wood, and Bolte.
  • postponed other items to next call